A Phase 4 Study Investigating the Efficacy of Retaineâ„¢ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
Phase 4
Completed
- Conditions
- Keratoconjunctivitis Sicca
- Interventions
- Drug: Retaineâ„¢
- First Posted Date
- 2014-05-15
- Last Posted Date
- 2014-06-11
- Lead Sponsor
- Ocusoft, Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT02139033
© Copyright 2025. All Rights Reserved by MedPath